How do psychedelics impact people with a history of non-affective psychosis? A qualitative study
Psychedelics might have heterogeneous impacts on people with NAPD, including both risks for harm and potential benefits. Our findings may assist in the development of safety and tolerability trials, highlighting the need for more nuanced work that examines how psychedelics impact people with NAPD.
Authors
- Peter S. Hendricks (ORCID: https://orcid.org/0009-0004-8642-9584)
- Jessica A. Turner (ORCID: https://orcid.org/0000-0003-0076-8434)
- Daniel H. Grossman
- Haley Maria Dourron (ORCID: https://orcid.org/0000-0002-1589-4081)
- Heith Copes (ORCID: https://orcid.org/0000-0001-8029-1837)
- Christopher R. Nicholas (ORCID: https://orcid.org/0000-0002-0599-4046)
- Melissa A. Bradley (ORCID: https://orcid.org/0000-0002-1293-8587)
- Maggie Gossage
- Gaige Allen-Clark
Institutions
- Linköping University (SE)
- University of Wisconsin–Madison (US)
- Ohio Department of Health (US)
- University of Alabama at Birmingham (US)
- Film Independent (US)
- University of Wisconsin Health (US)
- Institute for Behavioral Medicine (US)
- Wisconsin Division of Public Health (US)
- The Ohio State University (US)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-12-09
- DOI
- https://doi.org/10.3389/fpsyt.2025.1716545
- Citations
- 1
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.31